Quest Diagnostics
905 hedge funds and large institutions have $18B invested in Quest Diagnostics in 2021 Q4 according to their latest regulatory filings, with 152 funds opening new positions, 275 increasing their positions, 327 reducing their positions, and 69 closing their positions.
167% more funds holding in top 10
Funds holding in top 10: 3 → 8 (+5)
133% more call options, than puts
Call options by funds: $177M | Put options by funds: $76.3M
120% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 69
14% more capital invested
Capital invested by funds: $15.9B → $18B (+$2.17B)
8% more funds holding
Funds holding: 837 → 905 (+68)
4.03% less ownership
Funds ownership: 89.64% → 85.62% (-4%)
16% less repeat investments, than reductions
Existing positions increased: 275 | Existing positions reduced: 327
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$88.1M |
| 2 |
AssetMark Inc
Concord,
California
|
+$60.7M |
| 3 |
Renaissance Technologies
New York
|
+$53.3M |
| 4 |
Robeco Institutional Asset Management
Rotterdam,
Netherlands
|
+$39.4M |
| 5 |
N
Natixis
Paris,
France
|
+$31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$197M |
| 2 |
FMI
Fiduciary Management Inc
Milwaukee,
Wisconsin
|
-$152M |
| 3 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
-$112M |
| 4 |
Goldman Sachs
New York
|
-$104M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$98.9M |
DGX Hedge Fund Activity: Q4 2021 in Review
905 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2021, worth a combined $18B — up 14% from $15.9B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new DGX positions and 69 closed out — a net gain of 83 holders — while 275 added to existing stakes and 327 trimmed.
The largest buyer was Invesco, adding an estimated $88.1M. The largest seller was First Trust Advisors, cutting an estimated $197M.
- 905 institutional investors held Quest Diagnostics (DGX) as of Q4 2021, up from 837 in Q3 2021.
- Funds reported $18B of Quest Diagnostics stock for Q4 2021, up 14% quarter-over-quarter.
- 152 funds opened new Quest Diagnostics positions in Q4 2021 and 69 closed out, a net change of +83 holders.
- The largest Quest Diagnostics buyer in Q4 2021 was Invesco, an estimated $88.1M added.
- The largest Quest Diagnostics seller in Q4 2021 was First Trust Advisors, an estimated $197M sold.
Based on aggregated 13F filings for Q4 2021.